Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Non Operating Income (2017 - 2026)

Neuroone Medical Technologies filings provide 5 years of Other Non Operating Income readings, the most recent being $23446.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 23.02% to $23446.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $212149.0, a 175.3% increase, with the full-year FY2025 number at $170492.0, up 36.2% from a year prior.
  • Other Non Operating Income hit $23446.0 in Q1 2026 for Neuroone Medical Technologies, down from $46677.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $75432.0 in Q2 2025 to a low of -$26909.0 in Q1 2023.
  • Median Other Non Operating Income over the past 5 years was $30315.5 (2023), compared with a mean of $32968.1.
  • Biggest five-year swings in Other Non Operating Income: tumbled 79.36% in 2024 and later skyrocketed 396.14% in 2025.
  • Neuroone Medical Technologies' Other Non Operating Income stood at $51583.0 in 2022, then fell by 11.65% to $45575.0 in 2023, then tumbled by 79.36% to $9408.0 in 2024, then skyrocketed by 396.14% to $46677.0 in 2025, then plummeted by 49.77% to $23446.0 in 2026.
  • The last three reported values for Other Non Operating Income were $23446.0 (Q1 2026), $46677.0 (Q4 2025), and $66594.0 (Q3 2025) per Business Quant data.